🔎 Trials Near Me

Avaleht › Mania › Florida

Mania kliinilised uuringud osariigis Florida

5 uuringut haiguse Mania jaoks otsivad osalejaid osariigis Florida.

Linnad osariigis Florida

Ametlik uuringutekst (inglise keeles)

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

  • Neurocrine Clinical Site, Hollywood
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 29. sept 2026 · NCT07288320

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  • Behavioral Clinical Research, Hollywood
  • LCC Medical Research Institute, Miami
  • Innovative Clinical Research, Inc., Miami Lakes
  • ja veel 2
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 24. sept 2026 · NCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

  • Research Centers of America ( Hollywood ), Hollywood
  • Advanced Research Institute of Miami, Homestead
  • South Florida Research Phase I-IV, Miami
  • ja veel 3
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 22. sept 2026 · NCT06951698

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  • Velocity Clinical Research, Hallandale Beach, Hallandale
  • Local Institution - 0026, Hialeah Gardens
  • Behavioral Clinical Research, Hollywood
  • ja veel 7
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 14. sept 2026 · NCT06929273

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  • Velocity Clinical Research, Hallandale Beach, Hallandale
  • South Florida Research Phase I-IV, Miami
  • Health Synergy Clinical Research, West Palm Beach
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 23. juuni 2026 · NCT07140913

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.